Dive Brief: AbbVie announced Friday a new agreement with its longtime partner Gedeon Richter to research and develop dopamine-regulating treatments for neuropsychiatric diseases.   According …

Few things are as human as gazing into the night sky. And yet, after thousands of years, we know only a little about what we’re …

Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more …

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by …